P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 137 300 KRW -6.22% Market Closed
Updated: May 17, 2024
Section:
 

Relative Value

The Relative Value of one PharmaResearch Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 137 300 KRW, PharmaResearch Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PharmaResearch Co Ltd Relative Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Multiples

5.4
P/S
P/S
Price to Sales
5.4
vs History
33
vs Industry
64
Median 3Y
5
Median 5Y
5
Industry
8.2
Forward
4.5
More Details
18.3
P/E
P/E
Price to Earnings
18.3
vs History
57
vs Industry
8
Median 3Y
17.4
Median 5Y
18.9
Industry
27.4
Forward
14.2
More Details
21.6
P/OCF
P/OCF
Price to OCF
21.6
vs History
30
vs Industry
8
Median 3Y
15.2
Median 5Y
18.5
Industry
24.3
More Details
43
P/FCFE
P/FCFE
Price to FCFE
43
vs History
15
vs Industry
4
Median 3Y
29.4
Median 5Y
32.4
Industry
23
More Details
3.2
P/B
P/B
Price to Book Value
3.2
vs History
9
vs Industry
30
Median 3Y
2.7
Median 5Y
2.3
Industry
2.6
More Details
4.8
EV/S
EV/S
Enterprise Value to Sales
4.8
vs History
34
vs Industry
56
Median 3Y
4.4
Median 5Y
4.4
Industry
7.5
Forward
4
More Details
6.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.5
vs History
47
vs Industry
50
Median 3Y
6.2
Median 5Y
6.5
Industry
9.3
More Details
11.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.9
vs History
52
vs Industry
9
Median 3Y
11.2
Median 5Y
12
Industry
4.3
Forward
9.5
More Details
13.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
13.5
vs History
66
vs Industry
8
Median 3Y
13.2
Median 5Y
15.2
Industry
4.2
Forward
10.4
More Details
19.1
EV/OCF
EV/OCF
Enterprise Value to OCF
19.1
vs History
25
vs Industry
9
Median 3Y
13.8
Median 5Y
16.3
Industry
5.9
More Details
24
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
24
vs History
46
vs Industry
6
Median 3Y
21.6
Median 5Y
22.9
Industry
3.3
More Details
3.3
EV/IC
EV/IC
Enterprise Value to IC
3.3
vs History
9
vs Industry
41
Median 3Y
2.7
Median 5Y
2.3
Industry
4.9
More Details

Multiples Across Competitors

Competitors Multiples
PharmaResearch Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
PharmaResearch Co Ltd
KOSDAQ:214450
1.4T KRW 5.4 18.3 11.9 13.5
US
Abbvie Inc
NYSE:ABBV
290.2B USD 5.3 60.2 13.1 19.9
US
Amgen Inc
NASDAQ:AMGN
168.8B USD 5.7 44.9 18.9 31.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.6B USD 11.5 31.4 25.4 26.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
106.7B USD 8.1 27.7 22.3 24.8
AU
CSL Ltd
ASX:CSL
138.6B AUD 6.4 36.6 22.6 28
US
Gilead Sciences Inc
NASDAQ:GILD
84.6B USD 3.1 174.7 7 9.2
US
Moderna Inc
NASDAQ:MRNA
50.8B USD 9.9 -8.5 -9.4 -8.3
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
33.5B USD 3.5 28.7 14.6 18.2
KR
Celltrion Inc
KRX:068270
39.4T KRW 18.1 73.6 45 62

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.